Cigna Group $CI Holdings Trimmed by Gotham Asset Management LLC

Key Points

• Gotham Asset Management LLC has reduced its stake in Cigna Group (NYSE:CI) by 14.9%, now holding 63,694 shares worth approximately $20.96 million after selling 11,126 shares.
• Insider Nicole S. Jones sold 28,526 shares of Cigna, significantly decreasing her position by 52.66%, with the transaction valued at over $8.5 million.
• The latest earnings report revealed that Cigna's revenue increased by 11.0% year-over-year, with earnings per share of $7.20, surpassing expectations.

Gotham Asset Management LLC cut its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 14.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,694 shares of the health services provider's stock after selling 11,126 shares during the period. Gotham Asset Management LLC's holdings in Cigna Group were worth $20,955,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its stake in shares of Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Cigna Group by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock valued at $3,834,493,000 after acquiring an additional 98,715 shares in the last quarter. Dodge & Cox grew its stake in shares of Cigna Group by 1.3% during the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider's stock valued at $2,924,722,000 after acquiring an additional 117,125 shares in the last quarter. GQG Partners LLC grew its stake in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after acquiring an additional 865,092 shares in the last quarter. Finally, Parnassus Investments LLC grew its stake in shares of Cigna Group by 3.1% during the first quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider's stock valued at $949,357,000 after acquiring an additional 86,602 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.70% of the company's stock.

Cigna Group Stock Performance

Shares of CI traded up $1.24 during mid-day trading on Tuesday, reaching $302.13. 1,105,481 shares of the company's stock traded hands, compared to its average volume of 1,822,717. Cigna Group has a 12 month low of $256.89 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a market capitalization of $80.65 billion, a P/E ratio of 16.49, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48. The business's 50-day moving average price is $297.09 and its 200-day moving average price is $312.18.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business's revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group's payout ratio is 32.97%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CI. Wells Fargo & Company reduced their price target on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 14th. Guggenheim reaffirmed a "buy" rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Barclays increased their price target on shares of Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Cantor Fitzgerald reissued an "overweight" rating and issued a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Finally, Robert W. Baird set a $372.00 target price on shares of Cigna Group in a report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $374.76.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.